Page 113 - IJB-6-3

Bozo, et al.
Engineering. Tissue Eng Part A, 23:891–900.DOI: 10.1089/ Differentiation. J Clin Invest, 122:3101–13.DOI: 10.1172/
ten.tea.2016.0498. jci61209.
26. Gonzalez-Fernandez T, Rathan S, Hobbs C, 2019, Pore- 31. Bozo IY, Deev RV, Drobyshev AY, et al., 2015, Efficacy of
forming Bioinksto Enable Spatio-temporally Defined Gene-activated Osteoplastic Material Based on Octacalcium
Gene Delivery in Bioprinted Tissues. J Control Release, Phosphate and Plasmid DNA with VEGF Gene for Critical-
301:13–27.DOI: 10.1016/j.jconrel.2019.03.006. sized Bone Defects Substitution. N.N. Priorov Herald
27. Komlev VS, Barinov SM, Bozo IY, et al., 2014, Bioceramics Traumatol Orthop, 1:35–42.DOI: 10.32414/0869-8678-
Composed of Octacalcium Phosphate Demonstrate 2015-1-35-42.
Enhanced Biological Behaviour. ACS Appl Mater Interfaces, 32. Schertzer JD, Plant DR, Lynch GS, 2006, Optimizing
6:16610–20.DOI: 10.1021/am502583p. Plasmid-based Gene Transfer for Investigating Skeletal
28. Bozo IY, Deev RV, Drobyshev AY, et al., 2016, World’s First Muscle Structure and Function. Mol Ther, 13:795–803.DOI:
Clinical Case of Gene-activated Bone Substitute Application. 10.1016/j.ymthe.2005.09.019.
Case Rep Dent, 2016:8648949.DOI: 10.1155/2016/8648949. 33. Keeney M, van den Beucken JJ, van der Kraan PM, et al., 2010,
29. Yang YQ, Tan YY, Wong R, et al., 2012, The Role of Vascular The Ability of a Collagen/Calcium Phosphate Scaffold to Act
Endothelial Growth Factor in Ossification. Int J Oral Sci, 4:64–8. as its Own Vector for Gene Delivery and to Promote Bone
30. Liu Y, Berendsen AD, Jia S, et al., 2012, Intracellular VEGF Formation Via Transfection with VEGF (165). Biomaterials,
Regulates the Balance Between Osteoblast and Adipocyte 31:2893–902.DOI: 10.1016/j.biomaterials.2009.12.041.

International Journal of Bioprinting (2020)–Volume 6, Issue 3 109